Marshall Wace’s Mesoblast MESO Stock Holding History

Marshall Wace’s Portfolio MESO Stock Details MESO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$170K	Sell	11,057 -4,771	-30%	-$79.4K	﹤0.01%	2817
2025 Q4	$286K	Buy	+15,828	New	+$272K	﹤0.01%	2467
2025 Q3	–	Sell	-40,710	Closed	-$443K	–	3197
2025 Q2	$443K	Sell	40,710 -30,941	-43%	-$347K	﹤0.01%	2187
2025 Q1	$894K	Buy	+71,651	New	+$1.18M	﹤0.01%	1831
2024 Q4	–	Sell	-17,723	Closed	-$145K	–	2841
2024 Q3	$145K	Sell	17,723 -64,853	-79%	-$440K	﹤0.01%	2332
2024 Q2	$562K	Buy	+82,576	New	+$565K	﹤0.01%	1917
2023 Q1	–	Sell	-14,587	Closed	-$84.9K	–	2936
2022 Q4	$84.9K	Buy	+14,587	New	+$91.2K	﹤0.01%	2808
2020 Q2	–	Sell	-13,078	Closed	-$114K	–	1802
2020 Q1	$114K	Buy	+13,078	New	+$200K	﹤0.01%	1292

Other funds holding MESO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Penbrook Management New York $132M AUM 29.91% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Marshall Wace's MESO Position: Q1 2026 in Review

Marshall Wace reduced its Mesoblast (MESO) stake by 30% in Q1 2026, selling an estimated $79.4K and leaving 11,057 shares worth $170K. The position accounts for ﹤0.01% of the portfolio, ranked #2817.

Marshall Wace first reported a position in MESO in Q1 2020 and has held it in 8 quarters since. The position peaked at $894K in Q1 2025. 69 funds tracked by Wall St. Rank hold MESO as of Q1 2026.

Marshall Wace held 11,057 shares of Mesoblast worth $170K as of Q1 2026.
Marshall Wace sold 4,771 Mesoblast shares in Q1 2026, an estimated $79.4K.
Mesoblast made up ﹤0.01% of Marshall Wace's portfolio in Q1 2026, its #2817 holding.
Marshall Wace first reported a position in Mesoblast in Q1 2020 and has held it in 8 quarters since.
Marshall Wace's Mesoblast position peaked at $894K in Q1 2025.
69 funds tracked by Wall St. Rank held Mesoblast as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.